Dao Xin

487 total citations
20 papers, 253 citations indexed

About

Dao Xin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dao Xin has authored 20 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Dao Xin's work include Cancer Immunotherapy and Biomarkers (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Esophageal Cancer Research and Treatment (3 papers). Dao Xin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Gastric Cancer Management and Outcomes (4 papers) and Esophageal Cancer Research and Treatment (3 papers). Dao Xin collaborates with scholars based in China, United States and Sweden. Dao Xin's co-authors include Yan Zhu, Xiu Gao, Guanwei Fan, Feng Wang, Yao Lu, Feng Wang, Li Wang, Zhengzheng Shan, Yu Chen and Yuanyuan Yang and has published in prestigious journals such as Frontiers in Immunology, International Journal of Biological Macromolecules and Frontiers in Pharmacology.

In The Last Decade

Dao Xin

18 papers receiving 248 citations

Peers

Dao Xin
Guoqiang Liu China
Mengli Gu China
Runlan Luo China
Cui-Hong Zhu China
Yeon A. Choi South Korea
Haiyan Ma China
Xiaobing Liang China
Xiaoxun Zhang China
S. Theocharis Greece
Guoqiang Liu China
Dao Xin
Citations per year, relative to Dao Xin Dao Xin (= 1×) peers Guoqiang Liu

Countries citing papers authored by Dao Xin

Since Specialization
Citations

This map shows the geographic impact of Dao Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dao Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dao Xin more than expected).

Fields of papers citing papers by Dao Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dao Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dao Xin. The network helps show where Dao Xin may publish in the future.

Co-authorship network of co-authors of Dao Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Dao Xin. A scholar is included among the top collaborators of Dao Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dao Xin. Dao Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Bin, et al.. (2025). NRG1 fusion glycoproteins in cancer progression – Structural mechanisms and therapeutic potential: A review. International Journal of Biological Macromolecules. 323(Pt 1). 147057–147057.
2.
3.
4.
Yan, Haohao, Yuxin Cai, Dao Xin, et al.. (2024). Treatment strategies for limited-stage small cell carcinoma of the esophagus: evidence from a Chinese multicenter cohort study and the American SEER database. Journal of Thoracic Disease. 16(11). 7787–7796. 1 indexed citations
5.
Yang, Yuanyuan, et al.. (2024). Dual immunotherapy in advanced or metastatic non-small cell lung cancer: A network meta-analysis. Heliyon. 10(5). e27576–e27576. 4 indexed citations
6.
7.
Xin, Dao, et al.. (2023). A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. Journal of Inflammation Research. Volume 16. 1443–1455. 3 indexed citations
8.
Lu, Yao, Xi Luo, Dao Xin, et al.. (2023). Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth. Frontiers in Pharmacology. 14. 1141420–1141420. 5 indexed citations
9.
Tang, Jialin, Bo Zhang, Jianping Xu, et al.. (2022). Perioperative treatment and biomarker analysis of LP002, an anti‐PD‐L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer. Cancer Medicine. 12(5). 5639–5648. 3 indexed citations
10.
Chi, Yan‐Yan, Feng Wang, Yana Zhang, et al.. (2022). Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 26(7). 1905–1917. 11 indexed citations
11.
12.
Lu, Yao, Dao Xin, Yu Chen, et al.. (2021). Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Carcinoma by Inhibiting IL-6 Signaling Pathway. Frontiers in Oncology. 11. 762523–762523. 22 indexed citations
13.
Ma, Ping, Yanli Chen, Huayan Zhao, et al.. (2021). MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway. Hematology. 26(1). 931–939. 5 indexed citations
14.
Jiang, Guozhong, Dao Xin, Qingxia Fan, et al.. (2021). [Establishment and validation of prognostic risk score model for esophageal squamous cell carcinoma based on immune related genes].. PubMed. 43(6). 666–673. 3 indexed citations
15.
Wang, Feng, Dao Xin, Xiangrui Meng, & Qingxia Fan. (2021). 159 METFORMIN DOWNREGULATES PD-L1 EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA BY INHIBITING IL-6 SIGNALING PATHWAY. Diseases of the Esophagus. 34(Supplement_1).
16.
Lu, Yao, Dao Xin, & Feng Wang. (2019). <p>Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer</p>. OncoTargets and Therapy. Volume 12. 7791–7799. 33 indexed citations
17.
Xin, Dao, et al.. (2018). TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients. Recent Patents on Anti-Cancer Drug Discovery. 13(3). 341–347. 7 indexed citations
18.
Wu, Yuxiang, Dao Xin, Can Liu, & Feng Wang. (2018). [SIRT1 participates in epithelial-mesenchymal transition of EC-9706 and Eca-109 cells in vitro by regulating Snail expression].. PubMed. 38(11). 1325–1330. 1 indexed citations
19.
Xin, Dao, et al.. (2009). Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine. 17(2). 126–131. 119 indexed citations
20.
Hou, Ming, et al.. (2005). Effects of IgG and its F(ab′)2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation. European Journal Of Haematology. 76(2). 153–159. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoqiang Liu Breakdown of academic impact, for papers by Mengli Gu Breakdown of academic impact, for papers by Runlan Luo Breakdown of academic impact, for papers by Cui-Hong Zhu Breakdown of academic impact, for papers by Yeon A. Choi Breakdown of academic impact, for papers by Haiyan Ma Breakdown of academic impact, for papers by Xiaobing Liang Breakdown of academic impact, for papers by Xiaoxun Zhang Breakdown of academic impact, for papers by S. Theocharis
Rankless by CCL
2026